Charles A. Reitman, MD (Medical University of South Carolina Department of Orthopaedics), Michael Y. Wang, MD (University of Miami Hospital) and Michael D. Daubs, MD (University of Nevada Las Vegas School of Medicine) discuss degenerative scoliosis.

Disclosures:

Reitman, Charles A.: Board of Directors: NASS (Travel Expense Reimbursement); Other: NASS (Nonfinancial); Scientific Advisory Board: Clinical Orthopaedics And Related Research (B, Paid directly to institution/employer).

Wang, Michael Y.: Royalties: DePuy Synthes Spine (F); Stock Ownership: ISD (less than 1%), Medical Device Partners (less than 1%); Consulting: Stryker (C), Spineology (C), K2M (C), DePuy Synthes (C); Scientific Advisory Board: Vallum (A).

Daubs, Michael D.: Board of Directors: AO Spine North America (B, Paid directly to institution/employer),  Cervical Spine Research Society (Nonfinancial, Paid directly to institution/employer), Lumbar Spine Research Society (Nonfinancial, Paid directly to institution/employer); Other: The Spine Journal (B, Paid directly to institution/employer); Research Support (Investigator Salary): Pfizer (B, Paid directly to institution/employer); Royalties: Depuy Synthes (F, Paid directly to institution/employer).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+